Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Leap Therapeutics Inc’s current trading price is -79.71% away from its 52-week high, while its distance from the 52-week low is 67.61%. The stock’s price range during this period has varied between $1.24 and $10.20. The company, active in the Healthcare sector, saw a trading volume of around 0.51 million for the day, considerably higher average daily volume of 0.24 million observed over the last three months.
Leap Therapeutics Inc (LPTX) current stock price is $2.07. During the last trading session, the stock soared, reaching $2.2412 after opening at $1.85. The stock’s lowest point was $1.80 before it closed at $1.83.
In terms of market performance, Leap Therapeutics Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $10.20 on 06/01/23, while the lowest value was $1.24 on 10/02/23.
How Financial Performance Impacts Market Capitalization
Leap Therapeutics Inc (LPTX) has experienced a quarterly decline of -5.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 52.93M and boasts a workforce of 44 employees.
Decoding Analysts’ Ratings for Leap Therapeutics Inc
As of right now, 2 analysts are rating Leap Therapeutics Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.0500, with a change in price of -1.1200. Similarly, Leap Therapeutics Inc recorded 272,037 in trading volume during the last 100 days, posting a change of -35.11%.
How LPTX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for LPTX stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.00.
LPTX Stock Stochastic Average
As of today, the raw stochastic average of Leap Therapeutics Inc over the last 50 days is at 82.99%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 81.59%. Further, the company’s Stochastic %K and %D values for the last 20 days were 73.94% and 61.82%, respectively.
LPTX Stock Price Performance Analysis
The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Until today this year the stock’s price performance recorded a decrease of -54.00%. However, over the last six months, the performance has been stronger by -68.63%. The price of LPTX increased 37.09% over the last 30 days. And in the last five days, it has surged by 44.76%.